These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7696597)

  • 1. Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer's disease.
    Blennow K; Hesse C; Fredman P
    Neuroreport; 1994 Dec; 5(18):2534-6. PubMed ID: 7696597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E in cerebrospinal fluid from patients with Alzheimer's disease and other forms of dementia is reduced but without any correlation to the apoE4 isoform.
    Landén M; Hesse C; Fredman P; Regland B; Wallin A; Blennow K
    Dementia; 1996; 7(5):273-8. PubMed ID: 8872419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tau protein and apolipoprotein E in CSF diagnostics of Alzheimer's disease: impact on non Alzheimer's dementia?
    Rösler N; Wichart I; Bancher C; Jellinger KA
    J Neural Transm Suppl; 1996; 47():259-66. PubMed ID: 8841971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-dependent decline in the apolipoprotein E level in cerebrospinal fluid from control subjects and its increase in cerebrospinal fluid from patients with Alzheimer's disease.
    Fukuyama R; Mizuno T; Mori S; Yanagisawa K; Nakajima K; Fushiki S
    Eur Neurol; 2000; 43(3):161-9. PubMed ID: 10765057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E in cerebrospinal fluid in 85-year-old subjects. Relation to dementia, apolipoprotein E polymorphism, cerebral atrophy, and white matter lesions.
    Skoog I; Hesse C; Fredman P; Andreasson LA; Palmertz B; Blennow K
    Arch Neurol; 1997 Mar; 54(3):267-72. PubMed ID: 9074395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid lipoproteins in Alzheimer's disease.
    Bassett CN; Montine KS; Neely MD; Swift LL; Montine TJ
    Microsc Res Tech; 2000 Aug; 50(4):282-6. PubMed ID: 10936881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of apolipoprotein E (apoE) in cerebrospinal fluid.
    Hesse C; Larsson H; Fredman P; Minthon L; Andreasen N; Davidsson P; Blennow K
    Neurochem Res; 2000 Apr; 25(4):511-7. PubMed ID: 10823584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced CSF PLTP activity in Alzheimer's disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro.
    Vuletic S; Peskind ER; Marcovina SM; Quinn JF; Cheung MC; Kennedy H; Kaye JA; Jin LW; Albers JJ
    J Neurosci Res; 2005 May; 80(3):406-13. PubMed ID: 15795933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of cerebrospinal fluid apolipoprotein E in patients with Alzheimer's disease and healthy controls.
    Hahne S; Nordstedt C; Ahlin A; Nybäck H
    Neurosci Lett; 1997 Mar; 224(2):99-102. PubMed ID: 9086466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E levels in the cerebrospinal fluid of north Indian patients with Alzheimer's disease.
    Kandimalla RJ; Wani WY; Anand R; Kaushal A; Prabhakar S; Grover VK; Bharadwaj N; Jain K; Gill KD
    Am J Alzheimers Dis Other Demen; 2013 May; 28(3):258-62. PubMed ID: 23612909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease.
    Zimetti F; Caffarra P; Ronda N; Favari E; Adorni MP; Zanotti I; Bernini F; Barocco F; Spallazzi M; Galimberti D; Ricci C; Ruscica M; Corsini A; Ferri N
    J Alzheimers Dis; 2017; 55(1):315-320. PubMed ID: 27662294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid apolipoprotein E level is increased in late-onset Alzheimer's disease.
    Merched A; Blain H; Visvikis S; Herbeth B; Jeandel C; Siest G
    J Neurol Sci; 1997 Jan; 145(1):33-9. PubMed ID: 9073026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease.
    Johansson P; Almqvist EG; Bjerke M; Wallin A; Johansson JO; Andreasson U; Blennow K; Zetterberg H; Svensson J
    J Alzheimers Dis; 2017; 59(3):1017-1026. PubMed ID: 28697566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced levels of cholesterol, phospholipids, and fatty acids in cerebrospinal fluid of Alzheimer disease patients are not related to apolipoprotein E4.
    Mulder M; Ravid R; Swaab DF; de Kloet ER; Haasdijk ED; Julk J; van der Boom JJ; Havekes LM
    Alzheimer Dis Assoc Disord; 1998 Sep; 12(3):198-203. PubMed ID: 9772023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid lipoprotein delivery to human neuronal cells is increased in Alzheimer's disease and is dependent on apoE monomer concentration.
    Bassett CN; Swift LL; Montine KS; Markesbery WR; Montine TJ
    J Alzheimers Dis; 2002 Feb; 4(1):19-30. PubMed ID: 12214015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E, transthyretin and actin in the CSF of Alzheimer's patients: relation with the senile plaques and cytoskeleton biochemistry.
    Merched A; Serot JM; Visvikis S; Aguillon D; Faure G; Siest G
    FEBS Lett; 1998 Mar; 425(2):225-8. PubMed ID: 9559653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
    Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
    Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The apolipoprotein E allele epsilon 4 does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimer's disease.
    Landén M; Thorsell A; Wallin A; Blennow K
    J Neurol Neurosurg Psychiatry; 1996 Oct; 61(4):352-6. PubMed ID: 8890772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E4 accelerates dementia and increases cerebrospinal fluid tau levels in Alzheimer's disease.
    Kanai M; Shizuka M; Urakami K; Matsubara E; Harigaya Y; Okamoto K; Shoji M
    Neurosci Lett; 1999 May; 267(1):65-8. PubMed ID: 10400250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.